• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Hematology

Latest News

ESA treatment before or early after regular transfusion therapy improved OS In lower-risk MDS, a new study found. | Image credit: MdBabul - stock.adobe.com
ESA Treatment Improves OS in Lower-Risk MDS

March 28th 2025

Erythropoiesis-stimulating agent (ESA) treatment before or early after regular transfusion therapy improved overall survival (OS) In lower-risk myelodysplastic syndromes (MDS), a new study found.

ASH logo | images: ASH
Amid NIH Cuts, ASH Expands Eligibility for Midcareer Research Awards

March 24th 2025

CAR T  | Image Credit: © Funny-stock.adobe.com
Overcoming CAR T Manufacturing Failure in LBCL

March 21st 2025

Woman taking pills from bottle | Image credit: Rawpixel.com – stock.adobe.com
In CLL, Zanubrutinib Shows Better Safety Profile Than Ibrutinib

March 20th 2025

Orca-T is manufactured with highly purified regulatory T cells, hematopoietic stem cells, and conventional T cells from peripheral blood from matched donors. | Image credit: fotogurmespb - stock.adobe.com.jpg
Orca-T Immunotherapy Improves cGVHD-Free Survival in ALL, AML, MDS

March 20th 2025

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.